UniProt ID | CADH5_HUMAN | |
---|---|---|
UniProt AC | P33151 | |
Protein Name | Cadherin-5 | |
Gene Name | CDH5 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 784 | |
Subcellular Localization |
Cell junction . Cell membrane Single-pass type I membrane protein . Found at cell-cell boundaries and probably at cell-matrix boundaries. KRIT1 and CDH5 reciprocally regulate their localization to endothelial cell-cell junctions. |
|
Protein Description | Cadherins are calcium-dependent cell adhesion proteins. They preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types. This cadherin may play a important role in endothelial cell biology through control of the cohesion and organization of the intercellular junctions. It associates with alpha-catenin forming a link to the cytoskeleton. Acts in concert with KRIT1 to establish and maintain correct endothelial cell polarity and vascular lumen. These effects are mediated by recruitment and activation of the Par polarity complex and RAP1B. Required for activation of PRKCZ and for the localization of phosphorylated PRKCZ, PARD3, TIAM1 and RAP1B to the cell junction.. | |
Protein Sequence | MQRLMMLLATSGACLGLLAVAAVAAAGANPAQRDTHSLLPTHRRQKRDWIWNQMHIDEEKNTSLPHHVGKIKSSVSRKNAKYLLKGEYVGKVFRVDAETGDVFAIERLDRENISEYHLTAVIVDKDTGENLETPSSFTIKVHDVNDNWPVFTHRLFNASVPESSAVGTSVISVTAVDADDPTVGDHASVMYQILKGKEYFAIDNSGRIITITKSLDREKQARYEIVVEARDAQGLRGDSGTATVLVTLQDINDNFPFFTQTKYTFVVPEDTRVGTSVGSLFVEDPDEPQNRMTKYSILRGDYQDAFTIETNPAHNEGIIKPMKPLDYEYIQQYSFIVEATDPTIDLRYMSPPAGNRAQVIINITDVDEPPIFQQPFYHFQLKENQKKPLIGTVLAMDPDAARHSIGYSIRRTSDKGQFFRVTKKGDIYNEKELDREVYPWYNLTVEAKELDSTGTPTGKESIVQVHIEVLDENDNAPEFAKPYQPKVCENAVHGQLVLQISAIDKDITPRNVKFKFILNTENNFTLTDNHDNTANITVKYGQFDREHTKVHFLPVVISDNGMPSRTGTSTLTVAVCKCNEQGEFTFCEDMAAQVGVSIQAVVAILLCILTITVITLLIFLRRRLRKQARAHGKSVPEIHEQLVTYDEEGGGEMDTTSYDVSVLNSVRRGGAKPPRPALDARPSLYAQVQKPPRHAPGAHGGPGEMAAMIEVKKDEADHDGDGPPYDTLHIYGYEGSESIAESLSSLGTDSSDSDVDYDFLNDWGPRFKMLAELYGSDPREELLY | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
61 | N-linked_Glycosylation | MHIDEEKNTSLPHHV CCCCCCCCCCCCCCH | 37.87 | 21269602 | |
62 | Phosphorylation | HIDEEKNTSLPHHVG CCCCCCCCCCCCCHH | 42.58 | 24719451 | |
63 | Phosphorylation | IDEEKNTSLPHHVGK CCCCCCCCCCCCHHH | 49.66 | 24719451 | |
82 | Phosphorylation | VSRKNAKYLLKGEYV CCCCCHHHEECCEEE | 18.17 | - | |
112 | N-linked_Glycosylation | IERLDRENISEYHLT EEECCCCCCCCEEEE | 43.94 | 19139490 | |
157 | N-linked_Glycosylation | VFTHRLFNASVPESS EEEEEEECCCCCCHH | 35.58 | 21269602 | |
212 | Phosphorylation | SGRIITITKSLDREK CCCEEEEECCCCHHH | 13.11 | - | |
223 | Phosphorylation | DREKQARYEIVVEAR CHHHHHCEEEEEEEE | 17.02 | - | |
362 | N-linked_Glycosylation | NRAQVIINITDVDEP CCEEEEEEEECCCCC | 21.71 | 21269602 | |
392 | Phosphorylation | QKKPLIGTVLAMDPD CCCCCEEEEEEECHH | 12.83 | - | |
408 | Phosphorylation | ARHSIGYSIRRTSDK HHHHHCEEEEECCCC | 12.38 | 24719451 | |
442 | N-linked_Glycosylation | REVYPWYNLTVEAKE CCCCCEEEEEEEEEE | 25.93 | 19139490 | |
523 | N-linked_Glycosylation | FILNTENNFTLTDNH EEEECCCCEEECCCC | 25.66 | 16335952 | |
535 | N-linked_Glycosylation | DNHDNTANITVKYGQ CCCCCCEEEEEEEEE | 28.55 | 16335952 | |
658 | Phosphorylation | GEMDTTSYDVSVLNS CCCCCCCCCHHHHHH | 20.48 | 16027153 | |
665 | Phosphorylation | YDVSVLNSVRRGGAK CCHHHHHHHHCCCCC | 16.91 | 22817900 | |
683 | Phosphorylation | PALDARPSLYAQVQK CCCCCCCCHHEECCC | 28.58 | 28442448 | |
685 | Phosphorylation | LDARPSLYAQVQKPP CCCCCCHHEECCCCC | 10.18 | 16909109 | |
725 | Phosphorylation | HDGDGPPYDTLHIYG CCCCCCCCCEEEEEC | 25.37 | - | |
731 | Phosphorylation | PYDTLHIYGYEGSES CCCEEEEECCCCCHH | 11.69 | 16027153 | |
733 | Phosphorylation | DTLHIYGYEGSESIA CEEEEECCCCCHHHH | 10.51 | 22817900 | |
774 | Phosphorylation | FKMLAELYGSDPREE HHHHHHHHCCCCHHH | 13.19 | 23403867 | |
776 | Phosphorylation | MLAELYGSDPREELL HHHHHHCCCCHHHHC | 30.77 | 23403867 | |
784 | Phosphorylation | DPREELLY------- CCHHHHCC------- | 29.18 | 27642862 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CADH5_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CADH5_HUMAN !! |
Kegg Disease | |
---|---|
There are no disease associations of PTM sites. | |
OMIM Disease | |
There are no disease associations of PTM sites. | |
Kegg Drug | |
There are no disease associations of PTM sites. | |
DrugBank | |
DB00480 | Lenalidomide |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-112; ASN-442; ASN-523 ANDASN-535, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-685, AND MASSSPECTROMETRY. |